Nonlinear will provide software from its well-respected TotalLab and Progenesis ranges to be added to the Invitrogen portfolio. These will be marketed alongside Invitrogen's proteomics solutions, most notably the company's broad platform in 1D and 2D gel electrophoresis. On an ongoing basis, the two companies will work together to integrate further their respective products and create an enhanced portfolio for researchers.
“Invitrogen has a stated policy of partnering with a variety of businesses to achieve the very best in life science technologies. This partnership is an excellent example of our continued emphasis in this area.”
John Spreadbury, Group Sales and Marketing Director of Nonlinear Dynamics and CEO, Nonlinear USA Inc., said, "By entering this agreement, Invitrogen is further strengthening its already broad product offering into new areas. It is expanding its existing portfolio to enable complete workflow support in critical applications. This gives the corporation an even greater claim to represent a single-stop provider for life science researchers in pharma, biotech and academia.
"Invitrogen has a stated policy of partnering with a variety of businesses to achieve the very best in life science technologies. This partnership is an excellent example of our continued emphasis in this area."
Amy Butler, Business Area Manager for Proteomics from Invitrogen added, "As our customers' needs grow and evolve, the web of partnership becomes even more crucial for success. By working closely with our customers, we identified this important step in the 1D and 2D workflows where we could bolster our offering. Nonlinear represents the perfect partner to fill this gap, with well-respected and well-established products into which they maintain high levels of ongoing investment. These not only offer us greater breadth in our product offering, but will also further enhance our existing products through effective integration."
About Invitrogen
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California and conducts business in more than 70 countries around the world. The company globally employs approximately 4,500 scientists and other professionals. For more information about Invitrogen, visit the company's web site at www.invitrogen.com.
About Nonlinear Dynamics Ltd
Established in 1989, Nonlinear Dynamics is a leading worldwide provider of bioinformatics solutions to the life science industry. The Company's innovative product portfolio comprises high-quality analysis and data mining tools for 1D and 2D electrophoresis gels, mass spectrometry data and microarrays, the core technologies of genomics and proteomics. Nonlinear sells and supports its products through its UK headquarters, its USA office, and its global network of partners and OEM resellers.
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
Email 
